0001209191-23-059636.txt : 20231222 0001209191-23-059636.hdr.sgml : 20231222 20231222200158 ACCESSION NUMBER: 0001209191-23-059636 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231221 FILED AS OF DATE: 20231222 DATE AS OF CHANGE: 20231222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shendelman Shoshana CENTRAL INDEX KEY: 0001775490 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38898 FILM NUMBER: 231511157 MAIL ADDRESS: STREET 1: C/O APPLIED THERAPEUTICS, INC. STREET 2: 340 MADISON AVENUE, 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10173 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Applied Therapeutics Inc. CENTRAL INDEX KEY: 0001697532 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 545 5TH AVENUE, SUITE 1400 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-220-9319 MAIL ADDRESS: STREET 1: 545 5TH AVENUE, SUITE 1400 CITY: NEW YORK STATE: NY ZIP: 10017 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-21 0 0001697532 Applied Therapeutics Inc. APLT 0001775490 Shendelman Shoshana C/O APPLIED THERAPEUTICS, INC. 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 1 1 1 0 President and CEO 0 Common Stock 2023-12-21 4 A 0 1100000 0.00 A 3696387 D Common Stock 2023-12-21 4 A 0 440000 0.00 A 4136387 D Common Stock 1750000 I See footnote Common Stock 1492094 I See footnote Common Stock 709720 I See footnote Common Stock 290280 I See footnote Common Stock 88397 I See footnote Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan (the "Plan"). Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on December 21, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each month thereafter, subject to the reporting person continuing to provide services through each such date. Consists of compensatory Restricted Stock Units granted under the Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. These compensatory Restricted Stock Units are subject to both performance and time-based vesting requirements, subject to the reporting person continuing to provide services through each such date. The performance-based vesting requirements shall be satisfied upon the issuer's stock price trading at or above $6.00 per share for twenty consecutive trading days during a four-year performance period. The time-based vesting requirements shall be satisfied on the same schedule as applies to the time-based awards referenced in footnote (1) above. Through a grantor retained annuity trust. Through a family trust controlled by the reporting person's spouse. Through the reporting person's spouse. Through a family trust controlled by the reporting person. Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner. /s/ Shoshana Shendelman 2023-12-22